Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

BACKGROUND: Neoadjuvant chemotherapy (NACT) could improve prognosis and survival quality of patients with local advanced gastric cancer (LAGC) by providing an opportunity of radical operation for them. However, no effective method could predict the efficacy of NACT before surgery to avoid the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ruihuan, Yang, Yupeng, Chen, Hao, Qin, Wenjun, Han, Jing, Gu, Yong, Pan, Yiqing, Cheng, Xi, Zhao, Junjie, Wang, Xuefei, Ren, Shifang, Sun, Yihong, Gu, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003487/
https://www.ncbi.nlm.nih.gov/pubmed/32042279
http://dx.doi.org/10.1186/s12014-020-9267-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003487/
https://www.ncbi.nlm.nih.gov/pubmed/32042279
http://dx.doi.org/10.1186/s12014-020-9267-8

Ejemplares similares